Innovita Biological Technology Co., Ltd. (SHA:688253)

China flag China · Delayed Price · Currency is CNY
30.52
-0.22 (-0.72%)
At close: Jul 11, 2025, 2:57 PM CST
-17.02%
Market Cap4.29B
Revenue (ttm)546.74M
Net Income (ttm)196.06M
Shares Out136.46M
EPS (ttm)1.44
PE Ratio21.85
Forward PE16.38
Dividend0.56 (1.78%)
Ex-Dividend DateJun 24, 2025
Volume2,357,769
Average Volume2,109,036
Open30.74
Previous Close30.74
Day's Range30.33 - 30.75
52-Week Range27.56 - 52.69
Beta1.08
RSI58.27
Earnings DateAug 29, 2025

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, focuses on the research and development, production and sales of POCT rapid diagnostic products. The company offers pathogen detection and joint detection of multiple pathogen; gastrointestinal virus testing; respiratory tract infections solutions; pregnancy test; hepatitis virus testing; and eugenics testing. The company was founded in 2006 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 547
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688253
Full Company Profile

Financial Performance

In 2024, SHA:688253's revenue was 621.39 million, an increase of 29.99% compared to the previous year's 478.02 million. Earnings were 246.86 million, an increase of 41.92%.

Financial Statements

News

There is no news available yet.